Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?

Completed · Phase 2/Phase 3

Conditions studied: Glaucoma

In brief

The investigators hypothesize that intracameral Triesence during glaucoma surgery will provide lower intraocular pressure through better control of ocular inflammation, thus leading to a more successful filtering procedure.

Key facts

Study ID

NCT00853905

Run by

Wills Eye

People needed

77

Starts

2009-02-01

Expected to finish

2012-01-01

Last updated by the study team

2018-07-10

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• glaucoma patients requiring surgery (Trabeculectomy or Express Shunt; Trabeculectomy plus Phacoemulsification and Interocular Lens Implant; Baerveldt Tube; Ahmed Tube; Molteno Tube)
• primary open angle glaucoma
• primary angle-closure glaucoma
• pseudoexfoliation glaucoma
• pigmentary glaucoma
• traumatic glaucoma
• neovascular glaucoma

You may not qualify if…

• patients that are pregnant, nursing, or not using adequate contraception
• any other eye surgery except cataract surgery
• an infection, inflammation, or any abnormality preventing measurement of eye pressure
• enrolled in another investigational study

Where it is running

• Wills Eye Institute — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.